A Risk-Benefit Assessment of Sildenafil in the Treatment of Erectile Dysfunction

By Vitezic D.  

Drug Safety, Vol. 24, Iss. 4, 2001-01 ,pp. : 255-265

Adis International

Access to resources Recommend Favorite

Pharmacological approaches to the treatment of obstructive sleep apnoea

By Kohler Malcolm   Bloch Konrad E   Stradling John R  

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 5, 2009-05 ,pp. : 647-656

Informa Healthcare

Access to resources Recommend Favorite

Sildenafil: efficacy, safety, tolerability and mechanism of action in treating erectile dysfunction

By Francis Sharron H   Corbin Jackie D  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 2, 2005-08 ,pp. : 283-293

Informa Healthcare

Access to resources Recommend Favorite

Correlation between Endothelial Dysfunction, Rho-associated Protein Kinase Activity, C-reactive Protein and Obstructive Sleep Apnoea Syndrome in Male Patients

By Zhang L   Zhuang J-H   Peng H   Huang J   Huang L-Q   Zhao Z-X  

The Journal of International Medical Research, Vol. 40, Iss. 6, 2012-11 ,pp. : 2183-2190

Field House Publishing

Access to resources Recommend Favorite

Pitfalls of clinical trials on pharmacological treatment for obstructive sleep apnoea: future directions

By Kohler Malcolm   Stradling John R  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 8, 2011-08 ,pp. : 1033-1037

Informa Healthcare

Access to resources Recommend Favorite